DD133237A5 - Verfahren zur herstellung neuartiger substituierter 2,3-alkylen-bis-(oxy)benzamide - Google Patents

Verfahren zur herstellung neuartiger substituierter 2,3-alkylen-bis-(oxy)benzamide

Info

Publication number
DD133237A5
DD133237A5 DD20042077A DD20042077A DD133237A5 DD 133237 A5 DD133237 A5 DD 133237A5 DD 20042077 A DD20042077 A DD 20042077A DD 20042077 A DD20042077 A DD 20042077A DD 133237 A5 DD133237 A5 DD 133237A5
Authority
DD
German Democratic Republic
Prior art keywords
benzamides
oxy
novel substituted
preparing novel
alkylene bis
Prior art date
Application number
DD20042077A
Other languages
English (en)
Inventor
Michel Thominet
Gerard Bulteau
Jacques Acher
Claude Collignon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of DD133237A5 publication Critical patent/DD133237A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD20042077A 1976-08-04 1977-08-03 Verfahren zur herstellung neuartiger substituierter 2,3-alkylen-bis-(oxy)benzamide DD133237A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
DD133237A5 true DD133237A5 (de) 1978-12-20

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
DD20042077A DD133237A5 (de) 1976-08-04 1977-08-03 Verfahren zur herstellung neuartiger substituierter 2,3-alkylen-bis-(oxy)benzamide

Country Status (37)

Country Link
JP (1) JPS57167914A (de)
AR (1) AR219709A1 (de)
AT (1) AT358034B (de)
AU (1) AU516033B2 (de)
BE (1) BE857350A (de)
BG (1) BG36496A3 (de)
CA (1) CA1114371A (de)
CH (1) CH629198A5 (de)
CS (1) CS216246B2 (de)
DD (1) DD133237A5 (de)
DE (1) DE2760414C2 (de)
DK (1) DK152366C (de)
EG (1) EG12716A (de)
ES (1) ES461175A1 (de)
FI (1) FI63938C (de)
GR (1) GR61351B (de)
HK (2) HK40382A (de)
HU (1) HU179064B (de)
IE (2) IE45646B1 (de)
IL (2) IL52644A0 (de)
IN (1) IN145473B (de)
LU (1) LU77897A1 (de)
MC (1) MC1154A1 (de)
MW (1) MW2077A1 (de)
NL (1) NL172063C (de)
NO (1) NO152133C (de)
NZ (1) NZ184816A (de)
OA (1) OA05728A (de)
PH (3) PH22114A (de)
PL (1) PL111071B1 (de)
PT (1) PT66865B (de)
RO (1) RO72963A (de)
SE (2) SE440776B (de)
SU (1) SU716523A3 (de)
YU (1) YU40005B (de)
ZA (1) ZA774701B (de)
ZM (1) ZM6077A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
AU516033B2 (en) 1981-05-14
PT66865B (fr) 1978-12-29
IN145473B (de) 1978-10-21
PT66865A (fr) 1977-08-01
EG12716A (en) 1979-09-30
CA1114371A (en) 1981-12-15
HU179064B (en) 1982-08-28
FI772362A (de) 1978-02-05
IE45647B1 (en) 1982-10-20
ZA774701B (en) 1979-01-31
NL7708616A (nl) 1978-02-07
PL200066A1 (pl) 1978-09-11
DK152366B (da) 1988-02-22
PH17710A (en) 1984-11-19
ZM6077A1 (en) 1979-05-21
AU2750777A (en) 1979-02-08
ES461175A1 (es) 1978-12-01
SE8206546D0 (sv) 1982-11-17
OA05728A (fr) 1981-05-31
AR219709A1 (es) 1980-09-15
DE2760414C2 (de) 1990-05-17
HK40482A (en) 1982-09-24
MC1154A1 (fr) 1978-04-17
BE857350A (fr) 1978-02-01
PL111071B1 (en) 1980-08-30
JPS57167914A (en) 1982-10-16
DK152366C (da) 1988-07-25
CS216246B2 (en) 1982-10-29
SE437027B (sv) 1985-02-04
IE45646L (en) 1978-02-04
BG36496A3 (en) 1984-11-15
RO72963A (ro) 1981-11-24
LU77897A1 (de) 1978-02-09
NO152133B (no) 1985-04-29
GR61351B (en) 1978-10-26
FI63938B (fi) 1983-05-31
SE7708849L (sv) 1978-02-05
NL172063B (nl) 1983-02-01
SE8206546L (sv) 1982-11-17
SU716523A3 (ru) 1980-02-15
YU188277A (en) 1983-01-21
PH18629A (en) 1985-08-23
IL66138A0 (en) 1982-09-30
FI63938C (fi) 1983-09-12
ATA569677A (de) 1980-01-15
IE802409L (en) 1978-02-04
HK40382A (en) 1982-09-24
NO152133C (no) 1985-08-07
PH22114A (en) 1988-06-01
SE453390B (sv) 1988-02-01
DK346977A (da) 1978-02-05
NL172063C (nl) 1983-07-01
IL52644A0 (en) 1977-10-31
SE440776B (sv) 1985-08-19
CH629198A5 (fr) 1982-04-15
IE45646B1 (en) 1982-10-20
JPS6259090B2 (de) 1987-12-09
MW2077A1 (en) 1978-12-13
NO772739L (no) 1978-02-07
NZ184816A (en) 1980-11-14
YU40005B (en) 1985-06-30
AT358034B (de) 1980-08-11

Similar Documents

Publication Publication Date Title
ATA205777A (de) Verfahren zur herstellung von neuen 1- oxadethiacephalosporinen
AT348990B (de) Verfahren zur herstellung von neuen n- acylierten benzamiden
DD131931A5 (de) Verfahren zur herstellung von spiro-hydantoin-verbindungen
DD136616A5 (de) Verfahren zur herstellung von 1,4:3,6-dianhydro-d-glucit-2-nitrat
DD131858A5 (de) Verfahren zur herstellung von 3-chlorcephemverbindungen
AT365177B (de) Verfahren zur herstellung neuer 2-formylchinoxalin-1,4-dioxid-zyanacetylhydrazo e
DD129326A5 (de) Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen
DD129443A5 (de) Verfahren zur herstellung von indazolyl-(4)-oxypropanolaminen
DD131470A5 (de) Verfahren zur herstellung von 2-oxy-5-isopropyliden-7-hydroxy-9-substituierten-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocinen
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
DD133237A5 (de) Verfahren zur herstellung neuartiger substituierter 2,3-alkylen-bis-(oxy)benzamide
AT348498B (de) Verfahren zur herstellung des neuen n-n-butyl- n-cetyl-6-amino-1-hexanols
ATA505976A (de) Verfahren zur herstellung des 5-cyan-4-metyl- oxazols(1,3)
ATA106776A (de) Verfahren zur herstellung des neuen 2,2'-bis- (dimethylsulfoniumathyl)-atherdijodids
AT354466B (de) Verfahren zur herstellung der neuen n,n- dimethylaminomethan-diphosphonsaeure
DD129214A5 (de) Verfahren zur herstellung von neuen 1,9-dihydroxy-hexahydrodibenzopyranen
AT352696B (de) Verfahren zur herstellung von cyclohexandion- (1,4)-tetramethyldiketal
DD132263A5 (de) Verfahren zur herstellung von 2,3-dichlor-1-(c eins-sieben)-alkoxybenzolen
AT350075B (de) Verfahren zur herstellung von 0,0-dimethyl-0- (2,2-dichlorvinyl)-thionophosphorsaeureester
ATA834378A (de) Verfahren zur herstellung von 2,6-pyridincarbon- saeure
AT351014B (de) Verfahren zur herstellung des neuen 2-methyl- 4-trifluormethylanilins
DD134640A5 (de) Verfahren zur herstellung von 1,1-dihalo-4-methyl-1,3-pentadien
DD132497A1 (de) Verfahren zur herstellung von neuen gona-4,9(10)-dienen
DD131089A1 (de) Verfahren zur herstellung von 2,5-dihydroxybenzensulfonaten
DD128359A5 (de) Verfahren zur herstellung von 5,6-dehydropenicillinen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee